REGN vs MSFT: Which Stock is Better?
Side-by-side comparison of Regeneron Pharmaceuticals Inc and Microsoft Corporation in 2026
REGN
Regeneron Pharmaceuticals Inc
$797.17
MSFT
Microsoft Corporation
$510.89
Key Metrics Comparison
| Metric | REGN | MSFT | Winner |
|---|---|---|---|
| Market Cap | $59.10B | $3.71T | MSFT |
| P/E Ratio | 13.91 | 33.89 | REGN |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 0.0% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze REGN
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is REGN or MSFT a better investment?
Comparing REGN and MSFT: Regeneron Pharmaceuticals Inc has a market cap of $59.10B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between REGN and MSFT?
REGN (Regeneron Pharmaceuticals Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: REGN or MSFT?
Based on P/E ratios, REGN trades at a lower multiple (13.9x vs 33.9x).
Which is growing faster: REGN or MSFT?
MSFT has higher revenue growth at 18.4% vs 0.0% for REGN.
Which company is more profitable: REGN or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for REGN.
Which is the larger company: REGN or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $59.10B for REGN.
Should I buy REGN or MSFT in 2026?
Both REGN and MSFT have investment merit. REGN trades at $797.17 while MSFT trades at $510.89. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between REGN and MSFT stock?
Key differences: Market Cap ($59.10B vs $3.71T), P/E Ratio (13.9x vs 33.9x), Revenue Growth (0.0% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy REGN or MSFT in 2026?
The choice between REGN and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between REGN and MSFT?
REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.